Susie Lee sold Edwards Lifesciences Corp (NYSE: EW)
Susie Lee (D-NV), a U.S. Representative, has disclosed 1 trade in Edwards Lifesciences Corp (EW) since 2019, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Susie Lee sold $1,001 - $15,000 of Edwards Lifesciences Corp (NYSE: EW) on March 20, 2019. Since that trade, EW is up +38.03% against the S&P 500 up +192.44%, an outperformance of -154.40%.
Data updated
Susie Lee's EW trades vs the price
EW is up +38.03% since Susie Lee sold on March 20, 2019, versus +192.44% for the S&P 500.
Performance since this trade
All Susie Lee EW trades
Susie Lee & EW trading FAQ
Is it legal for Susie Lee to trade Edwards Lifesciences Corp (EW) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Edwards Lifesciences Corp (EW), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Susie Lee sell EW?
Susie Lee disclosed a sale of $1,001 - $15,000 of Edwards Lifesciences Corp (EW) on March 20, 2019, according to public STOCK Act filings.
How has EW performed since Susie Lee's trade?
Since Susie Lee sold EW on March 20, 2019, the stock is up +38.03%, versus +192.44% for the S&P 500 over the same period, an outperformance of -154.40%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional EW trades?
Quantellect tracks every disclosed congressional trade in Edwards Lifesciences Corp (EW) on the Edwards Lifesciences Corp congressional trading page, which aggregates filings across all members of Congress.
Susie Lee's EW tradesAll congressional filings for Edwards Lifesciences CorpSusie Lee's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.